Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Return on Equity (2019 - 2025)

Health Catalyst (HCAT) has disclosed Return on Equity for 7 consecutive years, with 0.32% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity fell 9.0% year-over-year to 0.32%, compared with a TTM value of 0.32% through Sep 2025, down 9.0%, and an annual FY2024 reading of 0.19%, up 11.0% over the prior year.
  • Return on Equity was 0.32% for Q3 2025 at Health Catalyst, down from 0.28% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.19% in Q4 2024 and bottomed at 0.49% in Q2 2021.
  • Average Return on Equity over 5 years is 0.31%, with a median of 0.32% recorded in 2023.
  • The sharpest move saw Return on Equity dropped -15bps in 2021, then rose 19bps in 2022.
  • Year by year, Return on Equity stood at 0.29% in 2021, then fell by -11bps to 0.32% in 2022, then increased by 1bps to 0.32% in 2023, then skyrocketed by 39bps to 0.19% in 2024, then tumbled by -64bps to 0.32% in 2025.
  • Business Quant data shows Return on Equity for HCAT at 0.32% in Q3 2025, 0.28% in Q2 2025, and 0.2% in Q1 2025.